Gland Pharma

Update in progress

GLAND.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Gland Pharma Limited manufactures and sells injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and other markets. It conducts R&D on pharmaceutical APIs, including complex molecules such as low molecular weight heparins, corticosteroids, peptides, and cytotoxics. Its products span multiple therapeutic areas and it also offers contract development, dossier compilation, and technology transfer. Founded 1978, Hyderabad, India; subsidiary of Fosun Pharma Industrial Pte. Ltd.

Company score

Sentiment: 0.69; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.30; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.22; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.14; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.41; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive